Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers

AUTOR(ES)

Shyamsundar, Murali

FONTE

American Thoracic Society

RESUMO

Rationale: Simvastatin inhibits inflammatory responses in vitro and in murine models of lung inflammation in vivo. As simvastatin modulates a number of the underlying processes described in acute lung injury (ALI), it may be a potential therapeutic option.

Documentos Relacionados

• Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo.
• Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones
• Lipopolysaccharide-induced leptin release is neurally controlled
• Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis
• Lipopolysaccharide-induced lethality and cytokine production in aged mice.